基于人工智能评估的《体检人群骨关节健康蓝皮书》_39页_3mb

AI-Based Blue Paper on Joint Health of Medical Examination Population Summary

Report Overview

This document is a blue paper focusing on the joint health of medical examination populations, utilizing artificial intelligence (AI) technologies. It spans from November 2023 to January 2025, analyzing disease burden, risk factors, and AI applications in joint health assessment, including knee and hip joints. The paper references various studies, surveys, and data from organizations like iKangAI+, highlighting metabolic and lifestyle factors contributing to conditions like osteoarthritis.

Key Sections and Findings

• Chapter 1: AI-Based Joint Health Assessment:
  Evaluates AI tools (e.g., iKangAI+) for standardized joint health assessments, showing high user engagement with over 180,000 participants. Risk factors like Body Mass Index (BMI) ≥24 kg/m² and fasting blood glucose (FBG) ≥61 mmol/L are identified as major contributors to joint issues.

• Chapter 2, 3, and 4: Risk Factor Analysis:
  Provides detailed data analysis on BMI, FBG, triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC). For instance, BMI ≥24 kg/m² affects over 40% of the population in certain age groups, and FBG levels correlate with symptomatic knee osteoarthritis. Data from meta-analyses and cohort studies emphasize the role of obesity and diabetes in joint degradation.

• Chapter 5 and 6: AI Integration and Future Outlook:
  Discusses AI advancements in predictive modeling, with tools like iKangAI+ used for threat analysis and prevention strategies. The paper includes future plans for AI expansion up to 2030, involving partnerships and large-scale health initiatives, such as a 360° diagnostic system, though portions were corrupted.

Summary of Risk Factor Impact

• BMI: Increases risk of osteoarthritis, especially in aging populations (e.g., 40-59 years), with prevalence rates rising from 3% to over 40% across age groups.
• FBG: High blood sugar levels (≥61 mmol/L) are linked to higher joint disease incidence, affecting around 20-30% of adults.
• Blood Lipids: Elevated TG and LDL-C levels are associated with joint problems, supported by studies from 2016-2023, showing correlations in demographic data.
• Overall Trends: AI-based assessments reveal a growing disease burden, with data indicating significant variations by age and risk factor levels, advocating for early AI-driven interventions.

This blue paper underscores the importance of AI in predictive health analytics and calls for continued research and implementation to improve joint health outcomes globally.